Latent

Latent is a healthcare technology company focused on improving how health systems deliver pharmacy services and help patients obtain medication. Its enterprise pharmacy intelligence platform is powered by a clinical agentic engine designed to support work across the medication journey, from identifying patients who may qualify for treatment to helping them access and remain on therapy. The company describes its purpose as simplifying the journey to health so life-changing treatments reach the people who need them.

The platform brings together several workflows: identifying eligible patients, improving access to medicines, supporting compliant treatment and engaging patients during care. Latent says its engine works with clinical records, claims information, payer policies and drug labels to help pharmacy teams find relevant evidence and complete time-consuming operational tasks. Its stated use cases include surfacing patients who may otherwise be missed, assisting with prior authorizations and appeals, reviewing eligibility for financial-assistance programs, and supporting patients through treatment.

Latent presents its software as a way for health systems to expand pharmacy operations and handle higher volumes without equivalent increases in staffing. The company reports that its platform supports more than 60 health systems and over five million patient medication journeys annually. Its website names organizations including Mount Sinai Health System, Cleveland Clinic, Yale New Haven Hospital, AdventHealth, Mayo Clinic, UCSF Health and Ochsner Health among its customers. These figures and customer examples are company-published claims.

The company’s customer base consists primarily of health systems and their pharmacy and care teams. Latent’s materials describe the platform as operating within existing electronic health record environments and supporting the work of pharmacists and other clinical staff. Its stated goal is to reduce administrative burdens that can delay access to prescribed therapies, while helping health systems manage pharmacy operations and serve more patients.

Latent was founded by Sriram “Sri” Somasundaram and Rishabh Jain. In its company overview, Latent says it has raised $80 million from investors including Transformation Capital, Spark Capital, Conviction, General Catalyst and Y Combinator. The available official company materials reviewed do not state a founding year or provide a headquarters address, so those details are not included here.

Patient benefit is central to the mission Latent describes: the company says getting life-changing treatments to people should be simpler and that it is focused on fixing barriers in that journey. Its published values include putting patients first, caring deeply, starting promptly and driving outcomes. Latent also describes its team as working together on the problem; those values provide the clearest available account of its working culture.